Results 121 to 130 of about 35,539 (289)

Differences in measles antibody titers among IVIGs and hyperimmune globulins

Transfusion, Volume 65, Issue 5, Page 1026-1027, May 2025.
Camille Nelson Kotton, Yonit Tiberman, Tamar Auerbach, Roberto Meidler, Winston Ally   +4 more
wiley   +1 more source

Barriers to measles mumps rubella vaccine acceptance in the three southern border provinces of Thailand. [PDF]

Clin Exp Vaccine Res, 2023
Sirithammaphan U, Chaisang U, Pongrattanamarn K.   +2 more
europepmc   +1 more source

Points: Measles, mumps, and rubella vaccine [PDF]

, 1988
Betty J. Grundy, R H PARROTT
openalex   +1 more source

Reactogenicity and immunogenicity of a new measles-mumps-rubella vaccine containing RIT 4385 mumps virus strain in healthy Turkish children

The Turkish Journal of Pediatrics, 2000
A total of 44 children aged between 15-18 months were randomly vaccinated either with a new measles-mumps-rubella (MMR) vaccine (Priorix, SmithKline Beecham) or a commercially available MMR vaccine (MMR-II, Merck) to compare the reactogenicity and
G Kanra, M Ceyhan, E Ozmert
doaj  

Seroprotection to vaccine‐preventable diseases among workers at a Victorian tertiary hospital

Australian and New Zealand Journal of Public Health, 2016
Objective: To determine seroprotection for the vaccine‐preventable diseases (VPDs) measles, mumps, rubella, varicella and hepatitis B among new employees seen at a Victorian tertiary hospital staff clinic.
Eden C. Andrew, Katherine B. Gibney, Justin Denholm, Karin Leder   +3 more
doaj   +1 more source

Decline of mumps antibodies in Type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of Type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland [PDF]

, 1993
H. Hy�ty, M. Hiltunen, Antti Reunanen, Pauli Leinikki, Timo Vesikari, R Lounamaa, Jaakko Tuomilehto, H. K. �kerblom, L. Toivanen, Jaakko Kaprio, Åse Fagerlund, M. Flittner, Bo G. Gustafsson, C. H�ggqvist, A. Hakulinen, L. Herva, Pauliina Hiltunen, T. Huhtam�ki, N. -P. Huttunen, T Huupponen, Marko Hyttinen, T. Joki, R. Jokisalo, Murthy Kr, S. Kallio, U. Kaski, Mikael Knip, Loren Laine, Jani Lappalainen, J. M�enp��, A. -L. M�kel�, K. Niemi, A. Niiranen, A. Nuuja, P. Ojaj�rvi, Timo Otonkoski, K. Pihlajam�ki, S. P�ntynen, Jukka Rajantie, J. Sankala, J. Schumacher, M. Sillanp��, M. -R. St�hlberg, C. -H. Str�hlmann, T. Uotila, M. V�re, P. Varimo, G. Wettenstrand   +47 more
openalex   +1 more source

Effect of choice of measles-mumps-rubella vaccine on immediate vaccination pain in infants.

Archives of Pediatrics & Adolescent Medicine, 2004
OBJECTIVE To compare acute pain response to 2 measles-mumps-rubella vaccines. DESIGN Double-blind clinical trial. SETTING Hospital for Sick Children, Toronto, Ontario.
M. Ipp, E. Cohen, M. Goldbach, C. Macarthur   +3 more
semanticscholar   +1 more source

Immunogenicity and efficacy of the Hoshino strain of mumps (MMR Vaccine) in Iran [PDF]

, 2011
Background: Mumps is an infectious and common disease during childhood. The vaccination against some epidemic diseases like mumps has been introduced in national program. This report describes the immunogenicity and efficacy of Hoshino strain of mumps (
Avijgan, Majid., Hafziz, M., Kheiri, S., Mirzadeh, Farnoush., Moghni, M.   +4 more
core  

Should Mumps Be Higher Up on the Public Health Agenda in India? A Concern for Global Health Security

Medical Sciences, 2018
Mumps is a public health problem on a global scale caused by mumps virus, a member of family paramyxoviridae. An effective form of vaccination exists and is incorporated into routine immunization schedules in over 100 countries, usually in the form of ...
Syed Manzoor Kadri, Saleem-ur Rehman, Kausar Rehana, Ailbhe Helen Brady, Vijay Kumar Chattu   +4 more
doaj   +1 more source

Attitudinal and Demographic Predictors of Measles-Mumps-Rubella Vaccine (MMR) Uptake during the UK Catch-Up Campaign 2008–09: Cross-Sectional Survey

PLoS ONE, 2011
Background and Objective Continued suboptimal measles-mumps-rubella (MMR) vaccine uptake has re-established measles epidemic risk, prompting a UK catch-up campaign in 2008–09 for children who missed MMR doses at scheduled age.
Katrina F. Brown, G. Fraser, M. Ramsay, R. Shanley, N. Cowley, Johan van Wijgerden, Penelope Toff, M. Falconer, M. Hudson, John Green, J. Kroll, C. Vincent, N. Sevdalis   +12 more
semanticscholar   +1 more source